Athens, Greece, 12-14 October 2022
Clicking each of the link will open the file in PDF format (Adobe Reader needed).
The use of the content, even partial, is not allowed without the prior agreement of the author. Please contact EQALM (
| Topic | Presentation | Speaker |
| Wednesday | ||
| EQA for rare diseases | -- | Ursula Unterberger |
| Update on the roll out of the in vitro diagnostic medical devices regulation 2017/746 (IVDR) | -- | Christa Cobbaert |
| Thursday | ||
| Update on ISO 17043 / IEC 17043 | -- | Olivier Pierson |
| An example of providing EQA reports that become part of the participants quality management system | -- | Tony Badrick |
| Extended use of EQA-results | -- | Mathias Karlsson |
| Experiences in EQA for phlebotomy and urine sampling | -- | Jonna Pelanti |
| Development of an External Quality Assessment (EQA) Programme for Point of Care (POCT) Respiratory Viruses | -- | Gareth Davies |
| Biological Variation in haemostasis variables | -- | Martine van Essen-Hollestelle |
| Intra-type variability as a measure of the resilience to operator and environmental influences of POCT diagnostic devices | -- | Christoph Buchta |
| Patient Based EQA | -- | Rachel Marrington |
| Assessment and risk estimation of biotin interference in immunoassays | -- | Alexander Haliassos & Serafeim Karathanos |
| Expanding the availability and coverage of EQA programmes in Africa | -- | Beatrice van der Puije |
| Results from a comprehensive, international external quality assessment for SARS-CoV-2-specific antibody assays - the EQALM-SARSCoV-2 antibody study with 1704 participant laboratories from 65 countries | -- | Lukas Weseslindtner |
| Interest in low antibody control samples in viral serology - Methods of production/validation of samples | -- | Marcel Miedougé |
| -- | István Juhos | |
| WG Haemostasis: HIL survey in coagulation | -- | Ann Helen Kristoffersen |
| Adam Uldall Lecture | ||
| EQA, is there a benefit for the patient?! | -- | Piet Meijer |
| Friday | ||
| Category 5 or 6 EQA programs | Tony Badrick | |
| Why EQA providers should use commutable control material and how to perform commutability studies | Sverre Sandberg | |
| What to do when reference measurement procedures show different results? | Anja Kessler | |
| EQALM Central Database | Wim Coucke | |
| Harmonising Reference Intervals in Haematology | Barbara De la Salle | |
| Correlation between EQA data as a key to determine optimum EQA frequency | Wim Coucke | |
| Analytical performance specifications - What does a limit of total error mean and when can it be used | Wim Coucke (Mohamed Rida Soumali) | |
| EQA for POCT glucose - consequences for patient diagnostics | Anne Stavelin |